Monitoring the safety of the adjuvanted human papillomavirus vaccine, HPV-16/18-AS04: Protocol for a cohort study using electronic health records in Yinzhou, China
This protocol was developed to conduct population-wide surveillance of the bivalent HPV-16/18-AS04-adjuvanted human papillomavirus (HPV) vaccine in terms of uptake and safety outcomes including potential immune-mediated diseases (pIMDs) and pregnancy-related outcomes in China. The study will use ele...
Saved in:
| Main Authors: | Junting Yang, Sarah Welby, Zhike Liu, Siwei Deng, Guangxu Liu, Ruogu Meng, Yu Yang, Yixin Sun, Yunkun He, Ning Jiang, Zhenhua Wu, Keruo Liu, Dominique Rosillon, Catherine Cohet, Siyan Zhan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2378535 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Chinese girls and women aged 9 to 45 years, 2018–2020
by: Qianhui Wu, et al.
Published: (2023-12-01) -
Post-marketing surveillance for the safety of the quadrivalent human papillomavirus vaccine: a retrospective real-world study in China
by: Ruogu Meng, et al.
Published: (2025-12-01) -
Post-marketing study design to evaluate the effectiveness of the 9-valent and 4-valent HPV vaccines on serious HPV-related cervical disease in China
by: Yu Yang, et al.
Published: (2024-12-01) -
Intercept-Resend Attack on SARG04 Protocol: An Extended Work
by: Ali H. Yousif, et al.
Published: (2020-06-01) -
Les Modifications et Changements Opérés par la Loi 06-04 dans la Législation en Matière d'Assurance
by: Ahmed RAHAL
Published: (2015-12-01)